Lycopene Fights Liver Aging by Activating a Key Mitochondrial Cleanup Pathway
A mycotoxin found in moldy food accelerates liver cell aging, but lycopene counters it by triggering SIRT3-driven mitophagy — clearing damaged mitochondria.
Summary
Fumonisin B1 (FB1), a potent mycotoxin from Fusarium mold, damages chicken liver cells by blocking mitophagy — the cellular process that clears defective mitochondria — leading to ROS buildup, cell cycle disruption, and accelerated cellular senescence. Researchers found that lycopene, the red pigment antioxidant in tomatoes, counteracts these effects by restoring mitophagy. The protective mechanism depends on SIRT3, a mitochondrial protein that activates a FOXO3-BNIP3L signaling pathway. When SIRT3 was knocked down, lycopene lost its protective power, confirming this pathway is essential. The findings point to SIRT3 modulation as a potential therapeutic strategy against mycotoxin-induced liver toxicity.
Detailed Summary
Mycotoxin contamination in food and animal feed is a persistent public health and agricultural concern. Fumonisin B1 (FB1), produced by Fusarium molds, is among the most prevalent and harmful, with the liver as a primary target organ. Understanding how FB1 damages cells — and how natural compounds might counter it — is critical for both food safety and liver health research.
In this study, researchers exposed chicken hepatocytes to 25 μM FB1 for 24 hours, producing measurable functional and structural cellular damage. FB1 suppressed mitophagy, the selective autophagy process that removes dysfunctional mitochondria, resulting in reactive oxygen species (ROS) accumulation. Cells showed inhibited proliferation, disordered cell cycle progression, and hallmarks of accelerated cellular senescence — the state of irreversible growth arrest linked to aging and tissue dysfunction.
Lycopene (LYC), a carotenoid antioxidant abundant in tomatoes and red fruits, was shown to reverse FB1-induced senescence by restoring mitophagy in hepatocytes. Crucially, this protection required SIRT3, a NAD+-dependent deacetylase that regulates mitochondrial function. When SIRT3 was experimentally knocked down, lycopene's benefits were abolished, pointing to SIRT3 as an indispensable mediator. The specific pathway involved is FOXO3-BNIP3L, a mitophagy-signaling axis that SIRT3 activates to facilitate clearance of damaged mitochondria.
These findings are relevant beyond poultry health. The SIRT3-FOXO3-BNIP3L axis is conserved across species, and cellular senescence driven by mitochondrial dysfunction is a core mechanism in mammalian aging and age-related liver disease. Dietary lycopene or SIRT3-activating interventions could have translational value.
Key caveats include the use of an isolated chicken hepatocyte model, limiting direct applicability to human liver biology or in vivo conditions.
Key Findings
- FB1 exposure at 25 μM for 24h blocked mitophagy, elevated ROS, and accelerated hepatocyte senescence.
- Lycopene restored mitophagy and prevented FB1-induced cellular senescence in chicken liver cells.
- SIRT3 knockdown abolished lycopene's protective effects, confirming it as the essential mediator.
- The FOXO3-BNIP3L signaling pathway downstream of SIRT3 drives the protective mitophagy response.
- Targeting the SIRT3-FOXO3-BNIP3L axis is proposed as a therapeutic strategy for mycotoxin liver toxicity.
Methodology
This was an in vitro study using chicken hepatocytes exposed to 25 μM fumonisin B1 for 24 hours. Lycopene co-treatment and SIRT3 siRNA knockdown were used to dissect the mechanistic pathway. Outcomes included cell viability, ROS levels, cell cycle analysis, senescence markers, and mitophagy indicators.
Study Limitations
The study relies solely on an isolated chicken hepatocyte cell model, which may not fully replicate complex in vivo liver biology or human physiology. No animal or human data are presented, limiting translational confidence. The specific lycopene concentrations and dosing windows tested may not reflect physiologically achievable levels from diet.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: